Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026)
Charlotte's Web Holdings (CWBHF) reported Non-Current Assets of $43.6 million for Q1 2026, down 31.95% year-over-year from $64.0 million in Q1 2025, and down 3.01% quarter-over-quarter from $44.9 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Non-Current Assets data on file, last reported at $43.6 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $43.6 million, down 31.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.9 million (down 32.65% YoY), and the FY2025 annual result was $44.9 million, down 32.42% from the prior year.
- Non-Current Assets declined to $43.6 million in Q1 2026 per CWBHF's latest filing, from $44.9 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $83.9 million in Q4 2022 and troughed at $43.6 million in Q1 2026.
- A 5-year average of $66.8 million and a median of $70.6 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets climbed 20.78% in 2023, then sank 33.76% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $83.9 million in 2022, then decreased by 11.33% to $74.4 million in 2023, then declined by 10.64% to $66.5 million in 2024, then sank by 32.42% to $44.9 million in 2025, then retreated by 3.01% to $43.6 million in 2026.
- Business Quant data shows CWBHF's Non-Current Assets at $43.6 million in Q1 2026, $44.9 million in Q4 2025, and $47.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | 43.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.56 Mn |
| Dec 31, 2025 | 44.91 Mn |
| Sep 30, 2025 | 47.13 Mn |
| Jun 30, 2025 | 48.26 Mn |
| Mar 31, 2025 | 64.02 Mn |
| Dec 31, 2024 | 66.46 Mn |
| Sep 30, 2024 | 69.65 Mn |
| Jun 30, 2024 | 72.86 Mn |
| Mar 31, 2024 | 73.52 Mn |
| Dec 31, 2023 | 74.38 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 81.73 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 83.88 Mn |
| Sep 30, 2022 | 66.34 Mn |
| Jun 30, 2022 | 70.65 Mn |
| Mar 31, 2022 | 73.12 Mn |
| Dec 31, 2021 | 75.71 Mn |
| Dec 31, 2020 | 166.99 Mn |